 SAN DIEGO, Feb. 17, 2021 GLOBE NEWSWIRE -- Kura Oncology, Inc. Nasdaq: KURA, a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report fourth quarter and full year 2020 financial results before the open of U.S. financial markets on Wednesday, February 24, 2021. Kuras management will host a webcast and conference call at 8:00 a.m. ET 5:00 a.m. PT that day to discuss the financial results and provide a corporate update. 